Skip to main content
Equibles
TSHA $4.63 -2.32%
TSHA logo
TSHA · Taysha Gene Therapies, Inc.
Track TSHA — free

Use TSHA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TSHA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.63 -0.11 (-2.32%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$1.52B
Shares
325.83M
Volume · Oct 2 2.99M Avg daily vol (3M) 3.17M
All webcasts

Earnings call · FY2025 Q4

Taysha Gene Therapies, Inc. (TSHA) Q4 2025 Earnings Call

Concluded Mar 19, 2026
Mar 19, 2026 0 turns
Period
FY2025 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Regulatory Progress with FDA 54 Rett Syndrome Market Opportunity 29 TASHA-102 Clinical Development 21 Manufacturing and CMC Readiness 14 Commercial Readiness 9 Safety and Tolerability 3

Management tone

Confident

Net tone +72 · moderate hedging

Grounding quotes
  • “2025 was a year of significant execution for TASIA”
  • “This progress has set the stage for what we expect to be a transformative year ahead for TASIA”
  • “We remain on track to complete dosing in the second quarter of 2026”
  • “in what we've reported on to date, we've never seen a loss of any gain”

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $5.49M +171.3% YoY
Net income · derived Q4 -$27.85M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Mar 19, 2026 10-K report Filed Mar 19, 2026 Company webcastOpen the original investor-relations page
Full-screen source Call document

TSHA transcript alerts

Taysha Gene Therapies, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →